{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T10:34:10Z","timestamp":1789814050237,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1261,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"name":"Wellcome Trust","award":["063558\/Z\/01\/B"],"award-info":[{"award-number":["063558\/Z\/01\/B"]}]},{"name":"Bill and Melinda Gates Foundation Grand Challenge","award":["award 6_74"],"award-info":[{"award-number":["award 6_74"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.11.004","type":"journal-article","created":{"date-parts":[[2009,11,25]],"date-time":"2009-11-25T13:08:24Z","timestamp":1259154504000},"page":"1635-1641","source":"Crossref","is-referenced-by-count":62,"title":["Complex cytokine profiles induced by BCG vaccination in UK infants"],"prefix":"10.1016","volume":"28","author":[{"given":"Maeve K.","family":"Lalor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sian","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gorak-Stolinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary E.","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Blitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Branson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Fine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel M.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.11.004_bib1","unstructured":"World Health Organisation. Immunization, surveillance, assessment and monitoring. Reported estimates of BCG coverage; updated 16 December 2008, http:\/\/www.who.int\/vaccines\/globalsummary\/immunization\/timeseries\/tscoveragebcg.htm [accessed 08.05.09]."},{"issue":"8986","key":"10.1016\/j.vaccine.2009.11.004_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib3","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/ije\/22.6.1154","article-title":"Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis","volume":"22","author":"Rodrigues","year":"1993","journal-title":"Int J Epidemiol"},{"issue":"19","key":"10.1016\/j.vaccine.2009.11.004_bib4","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1016\/j.vaccine.2007.01.112","article-title":"Current status of TB vaccines","volume":"25","author":"Gupta","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.004_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.chom.2008.08.002","article-title":"Tuberculosis in Africa: learning from pathogenesis for biomarker identification","volume":"4","author":"Kaufmann","year":"2008","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib6","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1086\/597069","article-title":"Population differences in immune responses to Bacille Calmette-Guerin vaccination in infancy","volume":"199","author":"Lalor","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib7","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib8","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1084\/jem.178.6.2243","article-title":"Disseminated tuberculosis in interferon gamma gene-disrupted mice","volume":"178","author":"Cooper","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.11.004_bib9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJM199612263352602","article-title":"A mutation in the interferon gamma receptor gene and susceptibility to mycobacterial infection","volume":"335","author":"Newport","year":"1996","journal-title":"New Engl J Med"},{"issue":"9315","key":"10.1016\/j.vaccine.2009.11.004_bib10","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(02)08353-8","article-title":"BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies","volume":"359","author":"Black","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2009.11.004_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2334-8-9","article-title":"Persistence of the immune response induced by BCG vaccination","volume":"8","author":"Weir","year":"2008","journal-title":"BMC Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1054\/tuld.1998.0009","article-title":"Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis","volume":"79","author":"Bellamy","year":"1998","journal-title":"Tuber Lung Dis"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2009.11.004_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-1759(02)00092-3","article-title":"Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population","volume":"264","author":"Hussain","year":"2002","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.vaccine.2009.11.004_bib14","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2249.2009.03875.x","article-title":"Differential cytokine secretion and early treatment response in patients with pulmonary tuberculosis","author":"Djoba Siawaya","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/BF02171753","article-title":"Supernatants derived from CD8+ lymphocytes activated by mycobacterial fractions inhibit cytokine production. The role of interleukin-6","volume":"4","author":"Sussman","year":"1992","journal-title":"Biotherapy"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.004_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.coi.2006.03.017","article-title":"Expanding the effector CD4 T-cell repertoire: the Th17 lineage","volume":"18","author":"Harrington","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.11.004_bib17","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.1035999100","article-title":"IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist","volume":"100","author":"Nakae","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.004_bib18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1074-7613(02)00391-6","article-title":"Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses","volume":"17","author":"Nakae","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2009.11.004_bib19","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/3-540-37673-9_8","article-title":"The role of TNFalpha and IL-17 in the development of excess IL-1 signaling-induced inflammatory diseases in IL-1 receptor antagonist-deficient mice","volume":"56","author":"Ishigame","year":"2006","journal-title":"Ernst Schering Res Found Workshop"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cyto.2007.11.022","article-title":"IL-23 and IL-17 in tuberculosis","volume":"41","author":"Khader","year":"2008","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.004_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ni1449","article-title":"IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge","volume":"8","author":"Khader","year":"2007","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib22","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis Bacille Calmette-Guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.004_bib23","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/eji.200838693","article-title":"Pattern and diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease","volume":"39","author":"Sutherland","year":"2009","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.11.004_bib24","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1086\/596742","article-title":"IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB","volume":"199","author":"Pasquinelli","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.11.004_bib25","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.4049\/jimmunol.180.3.1962","article-title":"Distinct, specific IL-17- and IL-22-producing CD4+ T cell subsets contribute to the human anti-mycobacterial immune response","volume":"180","author":"Scriba","year":"2008","journal-title":"J Immunol"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2009.11.004_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.tube.2006.01.018","article-title":"Immune systems in developed and developing countries; implications for the design of vaccines that will work where BCG does not","volume":"86","author":"Rook","year":"2006","journal-title":"Tuberculosis (Edinb)"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.004_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1086\/315200","article-title":"Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis","volume":"181","author":"Seah","year":"2000","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1054\/tube.2001.0317","article-title":"Decreased IFN- gamma and increased IL-4 production by human CD8(+) T cells in response to Mycobacterium tuberculosis in tuberculosis patients","volume":"82","author":"Smith","year":"2002","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib29","first-page":"171","article-title":"Th1\/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens","volume":"81","author":"Surcel","year":"1994","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.vaccine.2009.11.004_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1086\/422532","article-title":"Increased Interleukin-4 production by CD8 and gammadelta T cells in health-care workers is associated with the subsequent development of active tuberculosis","volume":"190","author":"Ordway","year":"2004","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.004_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2249.1998.00636.x","article-title":"Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis","volume":"113","author":"North","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.11.004_bib32","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.it.2004.06.005","article-title":"IL-4 in tuberculosis: implications for vaccine design","volume":"25","author":"Rook","year":"2004","journal-title":"Trends Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib33","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4049\/jimmunol.150.2.353","article-title":"Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production","volume":"150","author":"Del Prete","year":"1993","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.11.004_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nri2097","article-title":"T(H)1 cells control themselves by producing interleukin-10","volume":"7","author":"O\u2019Garra","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.11.004_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/CVI.00368-07","article-title":"Mycobacterium bovis bacillus Calmette-Guerin induces CCL5 secretion via the Toll-like receptor 2-NF-kappaB and -Jun N-terminal kinase signaling pathways","volume":"15","author":"Mendez-Samperio","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2009.11.004_bib36","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1086\/429994","article-title":"Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis","volume":"41","author":"Algood","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.11.004_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tube.2007.08.009","article-title":"Granulocyte-macrophage colony stimulating factor-mediated innate responses in tuberculosis","volume":"88","author":"Szeliga","year":"2008","journal-title":"Tuberculosis (Edinb)"},{"issue":"12","key":"10.1016\/j.vaccine.2009.11.004_bib38","doi-asserted-by":"crossref","first-page":"8418","DOI":"10.4049\/jimmunol.179.12.8418","article-title":"Improved protection against disseminated tuberculosis by Mycobacterium bovis Bacillus Calmette-Guerin secreting murine GM-CSF is associated with expansion and activation of APCs","volume":"179","author":"Ryan","year":"2007","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.11.004_bib39","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1002\/eji.200737504","article-title":"Immunisation with BCG and recombinant MVA85A induces long-lasting, polyfunctional Mycobacterium tuberculosis-specific CD4+ memory T lymphocyte populations","volume":"37","author":"Beveridge","year":"2007","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.vaccine.2009.11.004_bib40","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09017514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T17:28:06Z","timestamp":1685208486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09017514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09017514"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.11.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}